(Q43604319)

English

Adenovector engineered interleukin-2 expressing autologous plasma cell vaccination after high-dose chemotherapy for multiple myeloma--a phase 1 study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Adenovector engineered interleukin-2 expressing autologous plasma cell vaccination after high-dose chemotherapy for multiple myeloma--a phase 1 study (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Trudel S

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Li Z

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Dodgson C

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Nanji S

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Wan Y

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Voralia M

6

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Hitt M

7

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Gauldie J

8

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Graham FL

9

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Stewart AK

10

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

publication date

1 May 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

846-854

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402077

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensification of the stem cell transplant induction regimen results in increased treatment-related mortality without improved outcome in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402077

7 January 2021

based on heuristic

inferred from DOI database lookup

Graft-versus-myeloma effect in two cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402077

7 January 2021

based on heuristic

inferred from DOI database lookup

Transfer of myeloma idiotype-specific immunity from an actively immunised marrow donor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402077

7 January 2021

based on heuristic

inferred from DOI database lookup

Modulation of anti-idiotypic immune response by immunization with the autologous M-component protein in multiple myeloma patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402077

7 January 2021

based on heuristic

inferred from DOI database lookup

Paracrine cytokine adjuvants in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402077

7 January 2021

based on heuristic

inferred from DOI database lookup

Malignant plasma cells are sensitive to LAK cell lysis: pre-clinical and clinical studies of interleukin 2 in the treatment of multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402077

7 January 2021

based on heuristic

inferred from DOI database lookup

Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402077

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402077

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402077

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-2-mediated modulation of plasma cell tumor growth in a model of multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402077

7 January 2021

based on heuristic

inferred from DOI database lookup

Adenovector-mediated gene delivery of interleukin-2 in metastatic breast cancer and melanoma: results of a phase 1 clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402077

7 January 2021

based on heuristic

inferred from DOI database lookup

Large scale and clinical grade purification of syndecan-1+ malignant plasma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402077

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolation of bone marrow plasma cells by negative selection with immunomagnetic beads

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402077

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunotherapy of metastatic malignant melanoma by a vaccine consisting of autologous interleukin 2-transfected cancer cells: outcome of a phase I study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402077

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene therapy with autologous, interleukin 2-secreting tumor cells in patients with malignant melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402077

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2402077

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Dimensions Publication ID

0 references

release_tbhxwuurbnesxdyp4cwg2jfltm

1 reference

https://api.fatcat.wiki/v0/release/tbhxwuurbnesxdyp4cwg2jfltm

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43604319&oldid=2206154803"